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Calcium/calmodulin-dependent protein kinase II delta ± does ageing mirror disease in the 
cardiovascular system? 
Claire McCluskey, Hanif Salleh and Susan Currie 
Strathclyde Institute of Pharmacy and Biomedical Sciences, Hamnett Building, University of 
Strathclyde, Glasgow G4 0RE, Scotland, UK 
Calcium/calmodulin±dependent protein kinase II delta (CaMKIId) plays a fundamental role 
in cardiac dysfunction and is known to be overexpressed and hyper-activated in the diseased 
heart. A role for CaMKIId in compromised cardiovascular function associated with ageing 
has yet to be established. Here we compare CaMKIId expression and oxidation (a novel route 
of enzyme activation) in the diseased and in the aged heart and vasculature. Using a 
minimally invasive transverse aortic banding (MTAB) mouse model of cardiac hypertrophy 
as our disease model, we investigated whether alterations in CaMKIId and oxidised CaMKII 
(ox-CaMKII) observed during cardiac disease are also a key feature of ageing, where 
oxidative stress is apparent. Myocardial function was assessed in vivo by echocardiography 
and compared with that of sham-operated animals. A significant increase in systolic blood 
pressure (110±6.3 vs 78±2.6, MTAB vs sham, n=4), mean arterial pressure (75±3.3 vs 60±2.6 
(mmHg), MTAB vs sham) and reduction in fractional shortening (39.4±4.4 vs 53.6±3.8  
(%FS) MTAB vs sham, n=7, p<0.05) was observed in the hearts from hypertrophied animals 
demonstrating successful surgical intervention. Post-mortem analysis revealed increased 
heart weight:body weight in MTAB animals (5.48±0.17 vs 4.32±0.01, MTAB vs sham, n=6, 
p<0.05). Quantitative immunoblotting of CaMKIId and ox-CaMKII expression in whole 
heart homogenates from MTAB animals showed significant up-regulation of both when 
compared to sham controls (YV07$%Y¶VVKDPQ S). 
Interestingly, similar results were obtained in hearts from aged animals. A significant 
increase in CaMKIId expression was evident in aged hearts (0.81±0.08 vs. 0.46±0.08 aged vs 
young, p=0.04, n=3) and preliminary data suggests ox-CaMKII levels also show an increase 
in comparison to young (1.5-fold increase, n=1). Similar experiments were also conducted in 
young and aged rat aortae to assess CaMKIId involvement in vascular function. Vessels from 
aged subjects showed a significant increase in wall thickness (16.4±0.9 vs. 28±1.5 (um), 
young vs. aged, p=0.002, n=3) which may suggest an altered phenotype comparable to that 
observed during disease. Further quantitative immunoblotting indicated that CaMKIId is 
highly expressed in the vasculature and initial results suggest some alterations in ox-CaMKII 
protein levels with ageing, parallel to that observed in the heart. Overall, this work highlights 
for the first time that ageing alone, produces similar physiological and biochemical 
alterations in the heart as observed during cardiac disease. In addition to this, preliminary 
data from the vasculature has revealed a similar trend, suggesting CaMKIIdmay play an 
important role in overall deterioration of cardiovascular function with progressive ageing.  
 
